The Cholangiocarcinoma Foundation
AMMF – The UK's only Cholangiocarcinoma Charity
Home | European Cholangiocarcinoma Network
Description: Meta description
Cholangiocarcinoma (CCA) is a heterogeneous group of malignancies with features of biliary tract differentiation. It is the second most common primary liver tumor type and accounts for around 3% of all gastrointestinal cancers. CCA is very deadly disease due to its aggressiveness, late diagnosis and treatment refractory nature. The incidence and mortality rates are increasing worldwide and the therapeutic options are limited. Radiotherapy, chemotherapy (palliative), surgical resection (available for 10-30%
As a group of active researchers with a broad interest in this clinical area, we have significantly contributed to the study into the pathophysiology of the biliary tree and development/onset of CCA, pursuing basic, translational and clinical research in an effort to identify treatment options with successful outcome for this type of cancer. Our laboratories have together with our colleagues for years generated many of the key advancements in this field. In this regard, we have created the “European Network
Dr. Jesus M. Banales
The Cholangiocarcinoma Foundation
AMMF – The UK's only Cholangiocarcinoma Charity
Home | European Cholangiocarcinoma Network